Recommended Topic Related To:

Neotrace-4

"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.

Dotarem is a gadolinium-based"...

Neotrace-4

DRUG DESCRIPTION

NEOTRACE® ㆆ4
Mixture of Four Trace Elements Additive For IV Use In Neonates After Dilution

Neotrace®-4 is a sterile, nonpyrogenic solution of four trace elements for use as an additive for total parenteral nutrition (TPN).

Each mL contains:

Zinc Sulfate heptahydrate (equivalent to Zinc 1.5 mg) 6.6 mg
Cupric Sulfate pentahydrate (equivalent to Copper 0.1 mg) 0.39 mg
Manganese Sulfate monohydrate (equivalent to Manganese 25 mcg) 77 mcg
Chromic Chloride hexahydrate (equivalent to Chromium 0.85 mcg) 4.36 mcg
Water for Injection, USP q. s.

Zinc Sulfate is chemically designated ZnSO4, a white crystalline compound freely soluble in water.

Cupric Sulfate is chemically designated CuSO4, a blue crystalline compound very soluble in water.

Manganese Sulfate is chemically designated MnSO4, a pale red, slightly efflorescent compound soluble in water.

Chromic Chloride is chemically designated CrCl3, a greenish compound, soluble in water.

pH (approximately 2.5) adjusted with sulfuric acid.

Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD